Oliver Hampton
0000-0001-9164-1070
Publication & Citation Trends
Publications
0 total
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma
Cited by 1
Semantic Scholar
Genomic Classification and Individualized Prognosis in Multiple Myeloma OA
Cited by 63
Semantic Scholar
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma OA
Cited by 3
Semantic Scholar
Abstract 3928: Genomic landscape and estimation of immune infiltration of soft tissue sarcoma histology subtypes from the ORIEN network
Cited by 0
Semantic Scholar
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma OA
Cited by 0
Semantic Scholar
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma OA
Cited by 5
Semantic Scholar
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma OA
Cited by 4
Semantic Scholar
Ex Vivo Mathematical Myeloma Advisor (EMMA) - a Clinical, Molecular, and Phenotypic Platform to Tailor Personalized Therapeutic Strategies for Multiple Myeloma
Cited by 2
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(54)
Peptidase Inhibition and Analysis
(28)
Cancer Genomics and Diagnostics
(25)
Acute Myeloid Leukemia Research
(20)
Protein Degradation and Inhibitors
(20)
Affiliations
ASTER
University of North Carolina at Chapel Hill
Compugen (Israel)
Nationwide Children's Hospital
Mayo Clinic